We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Vivos Therapeutics Inc (VVOS) USD0.0001

Sell:$2.46 Buy:$2.51 Change: $0.08 (3.11%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$2.46
Buy:$2.51
Change: $0.08 (3.11%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$2.46
Buy:$2.51
Change: $0.08 (3.11%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Vivos Therapeutics, Inc. is a medical technology company. The Company is focused on the development and commercialization of a suit of diagnostic and multi-disciplinary treatment modalities for patients with cranial and/or dentofacial abnormalities and an array of medical conditions, including mild to moderate obstructive sleep apnea (OSA) and snoring in adults. The Company's Vivos Method is a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities and/or mild to moderate OSA and snoring. The Company's program is to train dentists and offer them other value-added services in connection with their ordering and use of the Vivos System for patients is called the Vivos Integrated Practice program. The Vivos Method comprises of various products and services, such as Vivos Complete Airway Repositioning and/or Expansion (CARE) oral appliance therapy; VivosGuides; Vivos Versa; POD and Night Block, and VivosMyoCorrect.

Contact details

Address:
7921 Southpark Plaza,, Suite 210
LITTLETON
80120
United States
Telephone:
+ ()
Website:
https://vivos.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
VVOS
ISIN:
US92859E2072
Market cap:
$7.24 million
Shares in issue:
2.73 million
Sector:
Health Care Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • R. Kirk Huntsman
    Chairman of the Board, Chief Executive Officer, Co-Founder
  • Bradford Amman
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.